Compendia Bioscience Awarded $1.3 Million in SBIR Fast Track Funds

Compendia Bioscience, Inc. today announced the award of $1.3 million in SBIR Fast Track funds to incorporate micro-RNA data and analyses into the Oncomine platform.

Source: Compendia